New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up

In a pilot study, we showed that the intermittent administration of benznidazole in chronic Chagas disease patients resulted in a low rate of treatment suspension and therapeutic failure, as assessed by quantitative PCR (qPCR) at the end of treatment. Here, a 3-year posttreatment follow-up study of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Álvarez, María Gabriela, Ramírez, Juan Carlos, Bertocchi, Graciela, Fernández, Marisa, Hernández, Yolanda, Lococo, Bruno, Lopez-Albizu, Constanza, Schijman, Alejandro, Cura, Carolina, Abril, Marcelo, Laucella, Susana, Tarleton, Rick L., Natale, María Ailen, Castro Eiro, Melisa, Sosa-Estani, Sergio, Viotti, Rodolfo
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2020
Teme:
Clinical Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449225/
https://ncbi.nlm.nih.gov/pubmed/32571827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00439-20
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items